Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
CONCLUSION: PTI improves OS and RFS of the transplant HCC patients at a high risk for post-transplant death and tumor recurrence, which is attributed to suppressive effect of PTI on HCC recurrence.
PMID: 31602163 [PubMed - in process]
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Chao JS, Zhao SL, Ou-Yang SW, Qian YB, Liu AQ, Tang HM, Zhong L, Peng ZH, Xu JM, Sun HC Tags: World J Gastroenterol Source Type: research
More News: Brain Tumor | Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Glioma | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | Lung Cancer | Lung Transplant | Transplant Surgery | Transplants | Urology & Nephrology